c‐Src promotes tumor progression through downregulation of microRNA‐129‐1‐3p-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

c‐Src promotes tumor progression through downregulation of microRNA‐129‐1‐3p

Published:2020-01-17 Issue:2 Volume:111 Page:418-428
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Okuzaki Daisuke¹,Yamauchi Tomoe²,Mitani Fumie²,Miyata Mamiko²,Ninomiya Yuichi²,Watanabe Risayo²,Akamatsu Hiroki³,Oneyama Chitose²^ORCID

Affiliation:

1. Genome Information Research Center Research Institute for Microbial Diseases Osaka University Suita Japan

2. Division of Cancer Cell Regulation Aichi Cancer Center Research Institute Nagoya Japan

3. Department of Surgery Osaka Police Hospital Osaka Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14269

Reference45 articles.

1. Cell Transformation by the Viral src Oncogene

2. Regulation, substrates and functions of src

3. The interplay between Src and integrins in normal and tumor biology

4. Src in cancer: deregulation and consequences for cell behaviour

5. c-Src and cooperating partners in human cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitors and atherosclerosis: A close but complicated relationship;European Journal of Pharmacology;2023-09

2. A TGF-β-responsive enhancer regulates SRC expression and epithelial–mesenchymal transition-associated cell migration;Journal of Cell Science;2023-08-01

3. MiR-654-3p targets SRC to suppress tumor growth in non-small cell lung cancer;Cellular and Molecular Biology;2023-04-30

4. A novel TGF-β-responsive enhancer regulates SRC expression and epithelial–mesenchymal transition-associated cell migration;2022-11-25

5. SNAP23-Mediated Perturbation of Cholesterol-Enriched Membrane Microdomain Promotes Extracellular Vesicle Production in Src-Activated Cancer Cells;BIOL PHARM BULL;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3